Related by context. All words. (Click for frequent words.) 78 CD4 cell 78 CD4 count 69 viral loads 68 viral load 66 CD4 cells 64 CD4 64 HAART 63 cART 63 CD4s 62 antiretroviral therapy 62 viral suppression 62 undetectable viral load 61 median CD4 61 antiretroviral therapy ART 61 virologic failure 61 CD4 + cell 60 cells/mm3 60 neutrophil counts 60 hemoglobin concentrations 60 urate levels 60 baseline CD4 59 platelet counts 59 serum creatinine levels 59 cells μL 59 eGFR 59 HAART regimen 59 sustained virologic response 59 virologic suppression 58 virologic response 58 HbA1c levels 58 PSA nadir 58 CD4 + 58 HIV RNA 58 CD4 + T 58 hemoglobin A1c levels 58 alanine aminotransferase ALT 57 creatinine levels 57 PSADT 57 HIV infection 57 coinfected 57 serum HBV DNA 57 undetectable viral loads 57 mL/min/#.# m 2 57 SHBG levels 57 ARV therapy 57 copies ml 57 adiponectin levels 57 A1c levels 57 antibody titers 57 Prostate Specific Antigen PSA 57 HBV DNA 57 disease progression 56 HBeAg negative 56 serum testosterone 56 viremia 56 hydroxyvitamin D levels 56 HBeAg seroconversion 56 seroconversion 56 A1C levels 56 potent antiretroviral therapy 56 prostate specific 56 antibody titer 56 virological failure 56 serum PSA 56 HbA1C 56 virological suppression 56 platelet reactivity 56 virological response 56 HIV infected 56 copies mL 56 #.#ng/ml 56 antiretroviral treatment 56 virologically 56 platelet count 56 virologic responses 56 CD4 T 55 CMV infection 55 chlamydial infection 55 HBV DNA levels 55 serum potassium 55 homocysteine levels 55 ng dL 55 pCR 55 serum sodium 55 lymphocyte counts 55 lymphocyte count 55 anemia hemoglobin 55 serum calcium levels 55 mg dl 55 specific antigen PSA 55 serum calcium 55 antiviral therapy 55 neutrophil count 55 anti retroviral therapy 55 transaminase levels 55 HbA 1c levels 55 antiretroviral naïve 55 CIN3 55 basal cell nevus syndrome 55 telomere lengths 55 titers 55 serum phosphate 55 atazanavir 55 biochemical recurrence 55 CD# upregulation 55 nadir CD4 cell 54 HIV HCV coinfected 54 Hb A1C 54 serum concentrations 54 sustained virological response 54 antiretroviral ARV therapy 54 cells mcL 54 HCV infected 54 HCV RNA 54 albumin excretion 54 serum urate levels 54 folate intake 54 NNRTIs 54 HAART regimens 54 leukocyte count 54 serum clusterin levels 54 serum ALT 54 fasting triglyceride levels 54 cervical lesions 54 cubic millimeter 54 nmol L 54 creatinine clearance 54 genotypic resistance 54 antiretroviral regimen 54 umol L 54 PCA3 scores 54 MELD score 54 seroconverted 54 serum vitamin D 54 advanced adenomas 54 CD4 + cells 54 tipranavir ritonavir 54 hemoglobin concentration 54 mm ³ 54 thyroid stimulating hormone 53 glomerular filtration rate 53 nonfasting triglyceride levels 53 antigen PSA levels 53 colorectal neoplasia 53 homocysteine concentrations 53 thyrotropin levels 53 antiretroviral ARV treatment 53 dose cyclophosphamide 53 alanine aminotransferase 53 kidney function 53 cells uL 53 darunavir 53 lopinavir 53 severe neutropenia 53 troponin T 53 transferrin saturation 53 blood glucose concentrations 53 atypical hyperplasia 53 ovarian carcinoma 53 ritonavir boosted 53 posttransplant 53 hepatic fibrosis 53 placental malaria 53 mIU L 53 microlitre 53 viraemia 53 baseline LDH 53 receiving antiretroviral therapy 53 antibody responses 53 pg ml 53 systolic dysfunction 53 A1Cs 53 iPTH 53 seropositive 53 protease inhibitor PI 53 pg mL 53 mIU ml 53 active antiretroviral therapy 53 fasting blood glucose 53 undetectable HBV DNA 53 NNRTI 53 ARV treatment 53 liver histology 53 plasma folate 53 aminotransferases 53 bilirubin levels 53 rapid virologic response 53 paricalcitol 53 Antiretroviral Therapy 52 folate supplementation 52 androgen deprivation 52 elevated CRP 52 serum potassium levels 52 fasting glucose levels 52 glycated hemoglobin levels 52 lung function 52 endometrial thickness 52 renal function 52 rapid virological response 52 MMSE scores 52 pneumococcal vaccination 52 NNRTI resistance 52 CrCl 52 microliter 52 grade dysplasia 52 arterial thickening 52 serum HCV RNA 52 iPrEx study 52 penetrance 52 ng ml 52 μmol L 52 MetS 52 overt hypothyroidism 52 undetectable viral 52 CD4 lymphocyte count 52 HIV uninfected 52 single dose nevirapine 52 antiretroviral drugs 52 macroalbuminuria 52 CMV disease 52 antigen PSA 52 TT genotype 52 distant metastases 52 serum albumin 52 immunosuppression 52 mg/m2 dose 52 antihypertensive therapy 52 nonnucleoside reverse transcriptase inhibitors 52 pyrazinamide 52 PASI scores 52 seroprevalence 52 abnormal cytology 52 seropositivity 52 estimated glomerular filtration 52 LDL cholesterol levels 52 antiretrovirals 52 B7 H3 52 sulfadoxine pyrimethamine 52 CCyR 52 baseline neutrophil counts 52 coinfection 52 serum lipid levels 52 fasting glucose 52 abacavir lamivudine 52 systolic blood pressures 52 QALE 52 mg dL 52 triglyceride levels 52 Hb levels 52 serum IgE 52 serum prostate 52 HbF 52 BRCA mutation 52 thyroglobulin 52 KRAS mutations 52 lipid lowering therapy 52 mEq L 52 lactate dehydrogenase 52 Ad5 immunity 52 serum uric acid 52 moderate renal impairment 52 grade cervical intraepithelial 52 p = #.# [003] 51 BCG vaccinated 51 hemoglobin levels 51 initiating HAART 51 resected pancreatic cancer 51 BRAF mutation 51 thyroid hormone levels 51 nanomolar 51 BLLs 51 serum creatinine 51 virologic 51 osteopenic 51 APTIVUS r 51 HBeAg 51 prostate cancer CaP 51 antiretroviral regimens 51 nelfinavir 51 hsCRP levels 51 antihypertensive medications 51 indinavir 51 postoperative mortality 51 HbA1c 51 cystatin C 51 asymptomatic carotid stenosis 51 ribavirin therapy 51 PSA velocity 51 complete cytogenetic response 51 MSMB 51 efavirenz Sustiva 51 MELD scores 51 metastatic lung cancer 51 detectable HCV RNA 51 postexposure prophylaxis 51 mucosal healing 51 ng dl 51 HBsAg 51 HBV infection 51 #OHD levels 51 TDF FTC 51 tipranavir 51 lymphocytosis 51 aspartate aminotransferase 51 testosterone supplementation 51 HIV seroconversion 51 aminotransferase levels 51 initiating antiretroviral therapy 51 adenoma recurrence 51 grade gliomas 51 blood glucose levels 51 serum testosterone levels 51 serum phosphate levels 51 serum urate 51 HER2 overexpression 51 hydroxyurea 51 nmol liter 51 hemoglobin A1C 51 mmol l 51 nevirapine Viramune 51 HBV infections 51 peginterferon 51 advanced neoplasia 51 dose ritonavir 51 leukocytosis 51 sUA 51 telomere length 51 advanced adenoma 51 HbA 1c 51 HSCT 51 imatinib therapy 51 Antiretroviral therapy 51 nonpregnant women 51 serum LDL cholesterol 51 pT3 51 DAS# [002] 51 gestational hypertension 51 systolic blood pressure 51 plasma viremia 51 uric acid levels 51 adefovir 51 blood Phe levels 51 MS relapses 51 beta blocker therapy 51 EBRT 51 cobicistat 51 triglyceride concentrations 51 lactate dehydrogenase LDH 51 lamivudine 51 glycated hemoglobin 51 intensive statin therapy 51 anti HBs 51 lopinavir ritonavir Kaletra 51 recurrent VTE 51 mmol liter 51 virus HBV 51 serum folate 51 urine albumin 51 ejection fractions 51 thyroxine 51 procalcitonin 51 hemoglobin Hb 51 Viral load 50 GBV C 50 suppressive therapy 50 Retreatment 50 metastatic RCC 50 antimicrobial prophylaxis 50 ASCUS 50 NRTI backbone 50 RBC transfusions 50 VZV 50 CC genotype 50 raltegravir 50 fructose diet 50 μg dose 50 aminotransferase ALT 50 plasma HCV RNA 50 nocturnal hypoglycaemia 50 thyroid function 50 calcium intakes 50 ng mL 50 dose cohort 50 viremic 50 Chlamydia infection 50 euthyroid 50 TPV r 50 antiretroviral medication 50 virological 50 asymptomatic 50 coronary calcification 50 genital ulcers 50 ovarian function 50 poorer prognosis 50 colorectal adenoma 50 Inhibin B 50 μg dL 50 immune reconstitution 50 HIV prevalence 50 mRCC 50 plasma glucose 50 lipid elevations 50 cotrimoxazole 50 transgene expression 50 plasma triglycerides 50 preoperative chemotherapy 50 hypertensives 50 neoplasia 50 aromatase inhibitor therapy 50 CK MB 50 mm Hg systolic 50 creatinine 50 chronic hepatitis cirrhosis 50 BRCA carriers 50 enfuvirtide 50 proteinuria 50 fosamprenavir 50 fasting insulin 50 epithelial ovarian cancer 50 hepatitis C genotype 50 mediated immunity 50 bacteraemia 50 combination antiretroviral therapy 50 poor metabolizers 50 d dimer 50 RBC folate 50 undetectable HCV RNA 50 LV dysfunction 50 granulocyte 50 genotype 1b 50 lipid levels 50 HNSCC 50 trastuzumab Herceptin ® 50 autoantibody levels 50 LTBI 50 biochemical relapse 50 baseline HbA1c 50 HIV 50 atypical ductal hyperplasia 50 DAPT 50 HER2 expression 50 glycemia 50 liver transplant recipients 50 cisplatin chemotherapy 50 seroprotection 50 NRTIs 50 latent tuberculosis infection 50 antidepressant therapy 50 neoadjuvant chemotherapy 50 seropositive patients 50 telomerase activity 50 eosinophil count 50 #mmHg [002] 50 aldosterone antagonists 50 EBV infection 50 nucleoside naive 50 HPTN 50 saquinavir 50 insulin detemir 50 inflammatory biomarkers 50 grade cervical dysplasia 50 microalbumin test 50 low dose ritonavir 50 co trimoxazole 50 elevated LDH 50 CIN3 + 50 AZT zidovudine Retrovir 50 liver enzymes 50 Pneumocystis carinii pneumonia 50 adiponectin concentrations 50 aspartate aminotransferase AST 50 calorie diets 50 Triglyceride levels 50 grade astrocytomas 50 K#N 50 HBeAg positive 50 pertussis vaccination 50 ERCC1 50 elevated creatinine 50 transgenic rats 50 gallstone disease 50 HbA1C levels 50 BARACLUDE ® 50 tamoxifen therapy 50 μg ml 49 mycophenolate mofetil 49 EGFR mutations 49 log# copies mL 49 grade glioma 49 EDSS score 49 serum IGF 49 inhibin 49 abdominal adiposity 49 LVEF 49 glycosylated hemoglobin levels 49 % CI #.#-#.# [003] 49 EpCAM expression 49 lymph node metastasis 49 mcg dose 49 pmol L 49 subclinical hypothyroidism 49 seminoma 49 urine NGAL 49 plasma concentrations 49 highest tertile 49 NIHSS 49 Hydroxyurea 49 mCRPC 49 NRTI resistance 49 Fasting glucose levels 49 serodiscordant couples 49 multivariable analysis 49 NAbs 49 operable breast cancer 49 serum ferritin 49 subclinical hyperthyroidism 49 Cortisol levels 49 preoperative PSA 49 radioiodine therapy 49 PrEP 49 radiographic progression 49 prostate cancer CRPC 49 lopinavir ritonavir 49 androgen therapy 49 prostate specific antigen 49 sweat chloride 49 follicle stimulating hormone FSH 49 remission CR 49 cotinine levels 49 lipid lowering drugs 49 statin therapy 49 antiretroviral naive 49 HIV seronegative 49 symptom onset 49 SHPT 49 methotrexate therapy 49 systolic hypertension 49 BRCA mutations 49 Naive Patients 49 carotid IMT 49 μg L 49 trastuzumab 49 exhaled nitric oxide 49 KRAS mutant tumors 49 elevated serum creatinine 49 albuminuria 49 Kaplan Meier analysis 49 invasive ductal 49 glycosylated hemoglobin HbA1c 49 folate concentrations 49 serum TSH 49 systolic BP 49 atazanavir ritonavir 49 serum IgG 49 spontaneous preterm delivery 49 precancer 49 vitamin D intake 49 tuberculin skin testing 49 elevated transaminases 49 corticosterone levels 49 nonischemic cardiomyopathy 49 Bcl xL 49 zidovudine lamivudine 49 seronegative 49 subclinical cardiovascular disease 49 leukemia ALL 49 elevated ALT 49 sperm motility 49 EDSS scores 49 interferon ribavirin 49 viral titers 49 immunodeficient 49 lifesaving antiretroviral treatment 49 dose dexamethasone 49 cervical intraepithelial neoplasia 49 shorter telomeres 49 polycystic ovary syndrome PCOS 49 castrate resistant 49 ejection fraction 49 NSTE ACS 49 d4T stavudine Zerit 49 antiretroviral medications 49 g dL 49 HCV genotype 49 cTnT levels 49 lipid lowering medications 49 d4T 49 baseline A1C 49 tHcy 49 CLL cells 49 virologic response EVR 49 Valcyte 49 Viral Load 49 log# reduction 49 lowest tertile 49 PCa 49 CPAP adherence 49 chronic HCV infection 49 coinfected patients 49 adenoma 49 3TC lamivudine Epivir 49 warfarin therapy 49 smoldering multiple myeloma 49 onset idiopathic hypogonadism 49 recurrent genital herpes 49 gonococcal infections 49 triacylglycerol concentrations 49 serum thyroglobulin 49 chronic HBV 49 HAQ DI 49 Baseline characteristics 49 EGFR TKI 49 metabolic parameters 49 colorectal carcinoma 49 BRCA2 mutation carriers 49 hemoglobin A1c HbA1c 49 #mmHg [001] 49 pancreatic adenocarcinoma 49 fibrosis progression 49 lipoatrophy 49 liver biopsy 49 antidiabetic medication 49 ductal breast cancer 49 pneumococcal infection 49 mm3 49 glucose tolerance 49 CD8 responses 49 anagrelide 49 lamivudine refractory patients 49 fluvastatin 48 relapsed MM 48 bezafibrate 48 A1c 48 M#V mutation 48 prior chemotherapy regimens 48 tumor histology 48 HOMA IR 48 postmenopausal breast cancer 48 atherogenic dyslipidemia 48 BENICAR HCT 48 adrenal function 48 serum estradiol 48 stavudine 48 immunocompetent 48 antiviral efficacy 48 AST ALT 48 hs CRP 48 Hb 48 CHD mortality 48 CPE delta N 48 certolizumab 48 hypogonadal 48 fasting plasma glucose 48 #/#mmHg 48 #mg dose [002] 48 cranial irradiation 48 nulliparous women 48 sUA levels 48 eculizumab therapy 48 preeclamptic 48 prevalences 48 ADPKD 48 mutated K ras 48 K ras mutations 48 glomerular filtration 48 metabolic syndrome MetS 48 tumor recurrence 48 leukocyte counts 48 statin medications 48 serum PTH 48 plasma homocysteine levels 48 SIV infected 48 nmol l 48 MMSE score 48 CsA 48 Doxil ® 48 IgA 48 chronic GVHD 48 urinary symptoms 48 hepatorenal syndrome 48 breast carcinoma 48 #ng/ml 48 microsatellite instability 48 chemoradiotherapy 48 HGPIN 48 recurrent UTI 48 urine dipstick 48 statistical significance 48 hydroxychloroquine 48 serum phosphorus 48 alteplase 48 cubic milliliter 48 antibody titres 48 prescribed statins 48 -#.# log# 48 #OHD 48 nucleoside naive patients 48 magnesium intake 48 premenopausal 48 microalbumin 48 antiretroviral therapies 48 parasitaemia 48 g dl 48 IGFBP 48 DMARD 48 IU mL 48 nephrotoxicity 48 metastatic renal cell 48 corticosteroid dose 48 mammographic density 48 estrogen progestin therapy 48 ALT elevation 48 glioblastoma tumors 48 severe renal impairment 48 SUVmax 48 intact parathyroid hormone 48 undergone radical prostatectomy 48 mmHg systolic 48 cortisol levels 48 ApoB 48 anti retroviral treatment 48 viral kinetics 48 HIVAN 48 T2DM 48 polyp recurrence 48 prostate adenocarcinoma 48 HCV 48 dose statin therapy 48 SIV infection 48 CK # plasma concentrations 48 steatosis 48 latent TB infection 48 Follicular Lymphoma 48 interferon therapy 48 anti retroviral therapy HAART 48 UGT#A# * 48 plasma glucose levels 48 #mg/dL [001] 48 dosage regimens 48 oral antidiabetic medication 48 IPAH 48 bioavailable testosterone 48 glycated hemoglobin HbA1c 48 LEXIVA r 48 tertile 48 acute STEMI 48 hormonal therapy 48 ovulatory cycles 48 adjuvant radiation 48 gastric carcinoma 48 NRTI 48 severe rotavirus gastroenteritis 48 μg doses 48 cystectomy 48 exemestane 48 elevated LDL cholesterol 48 decitabine 48 odds ratios ORs 48 Circumcised men 48 bladder carcinoma 48 antihypertensive medication 48 imatinib 48 dose cytarabine 48 CRp 48 SCIg 48 S#A# [002] 48 Lp PLA2 48 inflammatory markers 48 reach statistical significance 48 mg kg dose 48 cTnI 48 dose atorvastatin 48 low expressors 48 ritonavir boosted protease inhibitor 48 hydroxyvitamin D 48 serum homocysteine 48 GH deficiency 48 IPTp 48 NATRECOR R 48 HIV tropism 48 plasma uric acid 48 nondepressed 48 bad cholesterol LDL 48 immunosuppressed patients 48 proliferative diabetic retinopathy 48 vicriviroc 48 evaluable subjects 48 FTC TDF 48 progression TTP 48 stage IIIB 48 OADs 48 osteopenia 48 treatment naļve 48 enlarged spleens 48 locoregional 48 IFN α 48 GnRH agonist 48 interquartile range 48 HCV genotype 1 48 H. pylori infection 48 IFN gamma 48 pelvic lymphadenectomy 48 adalimumab 48 microvascular complications 48 KRAS mutation 48 cotrimoxazole prophylaxis 48 Non Alcoholic Fatty 48 creatinine ratio 48 oropharyngeal cancer 48 diastolic pressure 48 chlamydia infections 48 Opportunistic infections 48 albumin excretion rate 48 chlamydial 48 hemoglobin A1c 48 APTIVUS 48 LV hypertrophy 48 lymph node dissection 48 plasma pharmacokinetics 48 creatine kinase 48 chlamydia infection 48 aciclovir 48 μg liter 48 intima media thickness 48 colorectal cancer CRC 48 de ath 48 dose Iluvien 48 selenium intake 48 HRQOL 48 clodronate 48 GnRH agonists 48 peginterferon alfa 2a 48 plasma leptin 48 non squamous NSCLC 48 undergoing radical prostatectomy 48 Insulin sensitivity 48 leptin concentrations 48 serum phosphorus levels 48 RBP4 48 ABC/3TC 48 D dimer 48 peg interferon 47 hepatic function 47 ALT normalization 47 URTI 47 irregular menstrual cycles 47 Serum creatinine 47 cirrhotic 47 Prostate Specific Antigen 47 IELT 47 BMD measurements 47 adjuvant therapies 47 thrombophilia 47 CD# + [002] 47 tenofovir 47 genotype 47 endometrial carcinoma 47 Median survival 47 dose ionizing radiation 47 cardiovascular mortality 47 concomitant medications 47 telomeres shorten 47 metastatic disease 47 tenofovir DF 47 transcriptase inhibitors NNRTIs 47 lumbar spine BMD 47 nondiabetics 47 Pred Forte 47 experienced virologic failure 47 stage IIIb IV 47 daunorubicin 47 curative resection 47 liver biopsies 47 intramuscular dose 47 rheumatoid factor 47 cortisol concentrations 47 Bacille Calmette Guerin BCG 47 metastatic renal cell carcinoma 47 IV bisphosphonates 47 fat vegan diet 47 serum glucose 47 systolic pressure 47 doxorubicin docetaxel 47 lymphopenia 47 Pegylated Interferon 47 amoxicillin clavulanate 47 ImmuKnow 47 cytogenetic responses 47 troponin 47 urinary oxalate 47 intravenous bisphosphonates 47 liver metastasis 47 Viread Emtriva 47 urate lowering therapy 47 sunitinib 47 AVODART 47 cryptococcal meningitis 47 SLNB 47 CVD mortality 47 antioxidant supplementation 47 mg QD 47 dose colchicine 47 estimated GFR 47 mcg dL 47 Apgar scores 47 cardiotoxicity 47 prehypertensive 47 detemir 47 response CCyR 47 microalbuminuria 47 axillary lymph nodes 47 % Confidence Interval 47 NHANES III 47 sFlt 1 47 mutant p# 47 urate 47 herpes infections 47 flutamide 47 leukaemias 47 STELARA ® 47 isoprostane 47 CI -#.# 47 cabazitaxel 47 thyroid stimulating hormone TSH 47 Disease Progression 47 undergoing bariatric surgery 47 Gag polymorphisms 47 renal dysfunction 47 thiazide diuretics 47 uninfected 47 hsCRP 47 preterm deliveries 47 β blocker 47 attending antenatal clinics 47 serum cholesterol 47 E selectin 47 plasma urate 47 slow progressors 47 nonvertebral fractures 47 CDAI 47 colorectal polyp 47 specific antigen 47 DAS# scores 47 renal impairment 47 relapsers 47 COMBIVIR 47 statistical significance p 47 AZOR 47 heavily pretreated 47 antiretroviral 47 acquired immunodeficiency syndrome 47 serum cortisol 47 PMTCT 47 Subgroup analyzes 47 ofpatients 47 valacyclovir 47 HCV antibody 47 mild renal insufficiency 47 immunological responses 47 protease inhibitors PIs 47 nonalcoholic steatohepatitis NASH 47 colorectal liver metastases 47 SCr 47 glargine 47 entecavir 47 Multicenter AIDS 47 #.#mmol l [002] 47 urinary albumin 47 dapagliflozin plus 47 BMPR2 47 metastatic prostate cancer 47 mL/min/#.# m2 47 adjuvant radiotherapy 47 pegylated interferon alfa 47 tenofovir FTC 47 folic acid intake 47 urinary iodine 47 endogenous EPO 47 cTnT 47 bone density 47 QTcF 47 placebo dexamethasone 47 EGFR mutation 47 dexamethasone Decadron 47 precancerous cervical lesions 47 Myelodysplastic Syndrome MDS 47 monoinfected 47 Therapy HAART 47 nucleotide analog 47 reflux symptoms 47 LEXIVA 47 HER2 positive tumors 47 troponins 47 IU ml 47 corrected QT interval 47 milligrams deciliter 47 candidemia 47 NPH insulin 47 atheroma volume